Domínguez-Cabello E, Martín-Rodríguez A, Pérez-San-Gregorio M A, Fernández-Jiménez E, Sousa-Martín J M, Bernardos-Rodríguez A
Faculty of Psychology, Department of Personality, Assessment, and Psychological Treatments, University of Seville, Seville, Spain.
Transplant Proc. 2012 Nov;44(9):2616-8. doi: 10.1016/j.transproceed.2012.09.106.
To determine whether differences in the coping strategies used by liver patients during the pretransplantation phase were a function of their relatives' level of anxiety.
We assessed 75 pre-liver transplantation patients and 75 relatives (one per patient). To assess relatives' anxiety status, we used the Hospital Anxiety and Depression Scale (HADS), and the Questionnaire of Coping with Stress in Cancer Patients (CAEPO) to study patients' coping strategies. Three subgroups of relatives were established as a function of their scores on the HADS anxiety subscale: normal anxiety (G(1)), dubious anxiety (G2), and clinical anxiety (G(3)). To verify intergroup differences in the coping strategies used by the patients, we used the nonparametric Kruskal-Wallis H test. We also performed pairwise comparisons with nonparametric Mann-Whitney U test (with Bonferroni's correction) and Cohen's d as an effect size index.
Focusing on the most relevant effect sizes, the pairwise contrasts indicated the following differences: a) normal anxiety (G(1)) and dubious anxiety (G(2)): seeking social support (d = 0.502); b) normal anxiety (G(1)) and clinical anxiety (G(3)): coping and active fighting (d = 0.607), self-control and emotional control (d = 0.658), and seeking social support (d = 0.944); and c) dubious anxiety (G(2)) and clinical anxiety (G(3)): coping and active fighting (d = 0.743), self-control and emotional control (d = 0.722), and seeking social support (d = 0.515).
In general, during the pre-liver transplantation study, the liver patients whose relatives showed clinical levels of anxiety used these three healthy coping strategies to a lesser extent: coping and active fighting, self-control and emotional control, and seeking social support.
确定肝移植术前患者所采用的应对策略差异是否与其亲属的焦虑水平有关。
我们评估了75例肝移植术前患者及其75名亲属(每位患者对应一名亲属)。为评估亲属的焦虑状态,我们使用了医院焦虑抑郁量表(HADS),并使用癌症患者应对压力问卷(CAEPO)来研究患者的应对策略。根据亲属在HADS焦虑分量表上的得分,将亲属分为三个亚组:正常焦虑组(G(1))、可疑焦虑组(G2)和临床焦虑组(G(3))。为验证患者所采用应对策略的组间差异,我们使用了非参数Kruskal-Wallis H检验。我们还使用非参数Mann-Whitney U检验(采用Bonferroni校正)和Cohen's d作为效应量指标进行两两比较。
关注最相关的效应量,两两对比显示出以下差异:a)正常焦虑组(G(1))和可疑焦虑组(G(2)):寻求社会支持(d = 0.502);b)正常焦虑组(G(1))和临床焦虑组(G(3)):应对与积极抗争(d = 0.607)、自我控制与情绪控制(d = 0.658)以及寻求社会支持(d = 0.944);c)可疑焦虑组(G(2))和临床焦虑组(G(3)):应对与积极抗争(d = 0.743)、自我控制与情绪控制(d = 0.722)以及寻求社会支持(d = 0.515)。
总体而言,在肝移植术前研究中,亲属表现出临床焦虑水平的肝移植患者较少使用这三种健康的应对策略:应对与积极抗争、自我控制与情绪控制以及寻求社会支持。